title: Serono pays $44m to settle promotion of multiple sclerosis drug.
authors.forename: Janice Hopkins
authors.initials: JH
authors.lastname: Tanne
mesh_terms: D000276:Adjuvants, Immunologic / Q000191:economics*; D035881:Compensation and Redress / Q000331:legislation & jurisprudence*; D004345:Drug Industry / Q000191:economics* / Q000331:legislation & jurisprudence; D006801:Humans; D000068556:Interferon beta-1a; D016899:Interferon-beta / Q000191:economics*; D008318:Malpractice / Q000191:economics / Q000331:legislation & jurisprudence*; D008389:Marketing of Health Services / Q000191:economics; D009103:Multiple Sclerosis / Q000188:drug therapy / Q000191:economics*; D014481:United States
chemical_list: D000276:Adjuvants, Immunologic; D016899:Interferon-beta; D000068556:Interferon beta-1a